Followers | 1447 |
Posts | 13605 |
Boards Moderated | 3 |
Alias Born | 09/16/2015 |
Friday, November 17, 2017 3:28:26 AM
For those who are caught up on my DD - read this excellent post by "frontloading" below -- pay careful attention as he might just make you some $$$
https://panjiva.com/Bizright-Llc/27933530
IT IS MY OPINION, that I alluded to TWO major new pieces of DD one might have discovered as we await $ATPT to be moved to CURRENT status as SEC reporting and audited.
1- HUGE REFERENCE To MERGER and ACQUISTIONS in the Works and being finalized at $ATPT in the very latest 10Q issued on Weds.
2- CLEAR CONNECTIONS again to Passalaqua and a huge MJ company with vape product lines and other brands - Bizright LLC ---- and this leaves the door wide open for BUDLIFE.net packaging products for MJ and terpenes, etc. The Bizright deal alone is $30mil in revenues for $SGMD in 2017. This can only get better and better now for $ATPT - as the prospects of Plantation Corp (budlife.net) going public via $ATPT or something quite similar involving a major MJ deal with Passalaqua especially with all the direct correlations to these MJ companies (public and private).
Recent PBAJ News
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 02/27/2024 10:30:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/21/2024 07:58:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 10:13:25 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 05:29:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:26:13 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 05:55:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 05:46:12 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 10/02/2023 08:23:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 04:37:39 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM